Nabriva to Present at the JMP Securities Life Sciences Conference
VIENNA, Austria and KING OF PRUSSIA, Pa., June 14, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:NBRV) – Nabriva Therapeutics AG, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents, with a focus on the …